Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle
Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle The drug is approved for the treatment of SMA in adults and children 2 months of age and older, Roche said adding that it was approved by the Indian health authorities after reviewing its efficacy and safety data from three global clinical studies designed to represent a broad spectrum of people living with SMA. https://ift.tt/eA8V8J
India received help from 52 countries during second wave of COVID-19, says Centre
India received help from 52 countries during second wave of COVID-19, says Centre Minister of State for External Affairs V Muraleedharan said in a written reply that India has imported 31.5 lakh units of Sputnik Component 1 and 4.5 lakh units of Sputnik Component 2 vaccine till date. https://ift.tt/eA8V8J
Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle
The drug is approved for the treatment of SMA in adults and children 2 months of age and older, Roche said adding that it was approved by the Indian health authorities after reviewing its efficacy and safety data from three global clinical studies designed to represent a broad spectrum of people living with SMA.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3zNB2JE
via gqrds
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3zNB2JE
via gqrds
Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle
Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle The drug is approved for the treatment of SMA in adults and children 2 months of age and older, Roche said adding that it was approved by the Indian health authorities after reviewing its efficacy and safety data from three global clinical studies designed to represent a broad spectrum of people living with SMA. https://ift.tt/eA8V8J
‘The war has changed’: Internal CDC document urges new messaging, warns delta infections likely more severe; "The delta variant of the coronavirus appears to cause more severe illness than earlier variants and spreads as easily as chickenpox..."
‘The war has changed’: Internal CDC document urges new messaging, warns delta infections likely more severe; "The delta variant of the coronavirus appears to cause more severe illness than earlier variants and spreads as easily as chickenpox..."
https://ift.tt/3iX8Rky July 30, 2021 at 05:41AM https://ift.tt/1R552o9
![]() |
submitted by /u/progress18 [link] [comments] |
Subscribe to:
Posts (Atom)
Subscribe UsPopular Posts
|

